Janus Henderson Sustainable Corporate Bond ETF (SCRD) Quote

From about 10 days ago, on the NV SOS site.

You should probably spend the 3 bucks, or whatever it is, to get a fresh copy of the Amendment for yourself.

Or not. IGPK needs good holders of the bag, before they reverse and transform into JFHE.

The stock is up 21% in pre hours. trading at $5.67

IMO, This is incredible arbitrage opportunity. The deal will go through, I am 100% sure and I am buying

Looks like they added "including offer price" this time:

Company’s ongoing discussions with the Buyer Parties could result in further delays to the commencement or consummation of the Offer, or in the Company or the Buyer Parties seeking remedies in accordance with, and modifications

Listening for 6 years to somebody who has cost you money and still believing him makes you what?

And kidding himself in the process

https://investorshub.advfn.com/uimage/uploads/2024/10/28/fztxscreating-your-own-meaning-is-just-like-tying-a-carrot-on-v0-px4l9zsc4i3c1.jpg

$ILLR It’s Official: Triller Has Become the Go-To Replacement for Users Fleeing TikTok in Light of the Pending Ban
https://graziamagazine.com/us/articles/triller-has-become-the-replacement-for-users-fleeing-tiktok-in-light-of-the-pending-ban/

Same 💩 different 🚽

https://investorshub.advfn.com/uimage/uploads/2024/10/28/sxkhodangling-carrot.png

$ILLR It’s Official: Triller Has Become the Go-To Replacement for Users Fleeing TikTok in Light of the Pending Ban
https://graziamagazine.com/us/articles/triller-has-become-the-replacement-for-users-fleeing-tiktok-in-light-of-the-pending-ban/

Palms are itching.

?

The 90.day mark will.be here soon.  If we are only still.hearing from one side of the story, you can belive Mike is 100 percent telling the truth.   

Must be something from years ago dude.. I'm not even sure that is from IGPK LOL... no name, date, stock symbol, nothing... nice try but I think you are full of chit...

DOGEX 💡Upchurch HI-DEAS 2

I ASSUME that the current compassionate use treatment price is basically cost. That means it does not include any development cost amortization or profit. If anyone has more insight in to that I'd appreciate additional information on that subject.

Compassionate use is well above cost

So in the end he "vigorously" failed to offer ANY defense w/in the allotted time.

Doesn't matter. At some point he will have tp defend VXIT, the SEC is not going to forget about this,although he has no real defense.
Many shares will have to be issued to pay for the Lawyers.

Some of the avenues of research for ampa or gabakines are interesting, but it is clear in filings and commentary that the company leadership is working on creating value along 3 platforms.

Ampakines - CX1739 DOD/SCI phase 2 and they mentioned ADHD with either CX1739 or CX717
Ga

One may wonder when the automobile was invented were people posting about the accidents, head on collisions and fires and comparing them to their horse and buggies?
“I ain’t getting into one of those, Jethro almost lost his life.”
They need to outlaw those things, they are scaring t

t would be nice to get some good official news on whats going on with IBAT at this time especially when the smackover regions holding all that lithium brine from Texas, Louisianna, and Arkansas..Galvanic Energys CEO Brent Wilson sold that 120,000 acres of prime lithium smackover brine to Exxon Mobi

The Distribution Agreement is amended. Parties specifically agree there are no further items in dispute. Teoxane gets Daxxify marketing rights in Australia and NZ. Tender start extension to Nov 1.

https://www.sec.gov/Archives/edgar/data/1479290/000114036124044317/ef20037731_8k.htm

It doesnt make sense for them to be trading on this expert market in the first place, so trying to guess when they emerge will be tough. They have a big DOD funded clinical "supposedly" to begin by end of this year or basically next 8 weeks. Is this going to happen or pushed to Q1 2025?

The beautiful thing...
https://nypost.com/wp-content/uploads/sites/2/2024/10/Front-cover-10-28-2024.jpg?resize=394,441&quality=90&strip=all&w=750

I do think it is both interesting and telling that they are spending effort the 6+ months on summarizing, publicizing information and details that make the case for their premier ampa and gaba compounds as both platforms are poised to be in clinicals soon.

VIRX ON THE MOVE